MARAVAI LIFESCIENCES HOLDINGS, INC. Annual Cost of Revenue in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Maravai Lifesciences Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from 2019 to 2023.
  • Maravai Lifesciences Holdings, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $36.8M, a 0.38% increase year-over-year.
  • Maravai Lifesciences Holdings, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $149M, a 11% decline year-over-year.
  • Maravai Lifesciences Holdings, Inc. annual Cost of Revenue for 2023 was $149M, a 12% decline from 2022.
  • Maravai Lifesciences Holdings, Inc. annual Cost of Revenue for 2022 was $169M, a 20.2% increase from 2021.
  • Maravai Lifesciences Holdings, Inc. annual Cost of Revenue for 2021 was $141M, a 76.5% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $149M -$20.2M -12% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $169M +$28.4M +20.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $141M +$60.9M +76.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $79.6M +$12.8M +19.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $66.8M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.